by Talking Medicines | Apr 14, 2021
Data insights firm Talking Medicines, specialist in ‘social intelligence’ for the pharmaceutical industry, has appointed Donna Lawson to the position of Head of Data Quality. A particularly good fit for the role, Donna brings with her over two decades’ experience...
by Talking Medicines | Mar 3, 2021
Pharma Business International spoke with Jo Halliday, CEO of Talking Medicines, the world’s first social intelligence company designed specifically for the pharmaceutical industry. The full article can be found here on page 10-11 Tell us about Talking Medicines?...
by Talking Medicines | Nov 4, 2020
Talking Medicines, the world’s first social intelligence company for the pharmaceutical industry, has received a significant boost with a £1.1 million funding deal to scale up its AI-based data technology platform for measuring patient sentiment. Tern Plc, the...
by Talking Medicines | Jan 8, 2018
With increasingly unmet pressures on the NHS straining resources this winter, new digital solutions offer a way to improve effective self-care across morbidities and a myriad of complex co-meds solutions. The Kings Fund has published a review of NHS performance over...
